CA1334416C - 4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds - Google Patents

4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds

Info

Publication number
CA1334416C
CA1334416C CA000580589A CA580589A CA1334416C CA 1334416 C CA1334416 C CA 1334416C CA 000580589 A CA000580589 A CA 000580589A CA 580589 A CA580589 A CA 580589A CA 1334416 C CA1334416 C CA 1334416C
Authority
CA
Canada
Prior art keywords
phenyl
ethyl
lower alkyl
piperidine
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000580589A
Other languages
English (en)
French (fr)
Inventor
Linas V. Kudzma
H. Kenneth Spencer
Sherry A. Severnak
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter International Inc
Original Assignee
Ohmeda Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ohmeda Inc filed Critical Ohmeda Inc
Application granted granted Critical
Publication of CA1334416C publication Critical patent/CA1334416C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CA000580589A 1987-11-02 1988-10-19 4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds Expired - Fee Related CA1334416C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/115,284 1987-11-02
US07/115,284 US4791121A (en) 1987-11-02 1987-11-02 4-phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds

Publications (1)

Publication Number Publication Date
CA1334416C true CA1334416C (en) 1995-02-14

Family

ID=22360366

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000580589A Expired - Fee Related CA1334416C (en) 1987-11-02 1988-10-19 4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds

Country Status (16)

Country Link
US (1) US4791121A (en, 2012)
EP (1) EP0315405B1 (en, 2012)
JP (2) JPH02152963A (en, 2012)
KR (1) KR970008313B1 (en, 2012)
CN (1) CN1020723C (en, 2012)
AU (1) AU611728B2 (en, 2012)
CA (1) CA1334416C (en, 2012)
DE (1) DE3854938T2 (en, 2012)
DK (1) DK172787B1 (en, 2012)
ES (1) ES2081810T3 (en, 2012)
FI (1) FI885035A7 (en, 2012)
GR (1) GR3019342T3 (en, 2012)
IL (1) IL88140A0 (en, 2012)
MX (1) MX9203140A (en, 2012)
NO (1) NO172691C (en, 2012)
NZ (1) NZ226634A (en, 2012)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4871749A (en) * 1987-12-31 1989-10-03 Boc, Inc. 4-heteropentacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharamaceutical compositions and method employing such compounds
US4868194A (en) * 1988-09-23 1989-09-19 Merrell Dow Pharmaceuticals Inc. Imidazole antiarrhythmics
KR900016129A (ko) * 1989-04-20 1990-11-12 테리 아아르 커세트 4-알콕시알킬-4-아미노페닐피페리딘 및 그들의 유도체의 제조 방법
US4939161A (en) * 1989-05-12 1990-07-03 Boc, Inc. Analgesic N-aryl-N-[1-substituted-3,5-dimethyl-4-piperidinyl]amides
FR2678267B1 (fr) * 1991-06-25 1994-02-04 Elf Sanofi Arylalkylamines, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2725986B1 (fr) * 1994-10-21 1996-11-29 Adir Nouveaux derives de piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6635661B2 (en) 2000-05-25 2003-10-21 Sepracor Inc. Heterocyclic analgesic compounds and methods of use thereof
US6677332B1 (en) 1999-05-25 2004-01-13 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
US7361666B2 (en) 1999-05-25 2008-04-22 Sepracor, Inc. Heterocyclic analgesic compounds and methods of use thereof
AR028948A1 (es) * 2000-06-20 2003-05-28 Astrazeneca Ab Compuestos novedosos
EP1966140A1 (en) * 2005-11-17 2008-09-10 Mallinckrodt, Inc. Process for synthesizing remifentanil

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE623427A (en, 2012) * 1961-10-10
US3161637A (en) * 1961-10-10 1964-12-15 Res Lab Dr C Janssen N V 1-(gamma-aroyl-propyl)-4-(nu-arylcarbonyl amino) piperidines and related compounds
US3998834A (en) * 1975-03-14 1976-12-21 Janssen Pharmaceutica N.V. N-(4-piperidinyl)-n-phenylamides and -carbamates
US4196210A (en) * 1975-09-23 1980-04-01 Janssen Pharmaceutica N.V. N-Aryl-N-(1-L-4-piperidinyl)-arylacetamides
US4584303A (en) * 1984-04-09 1986-04-22 The Boc Group, Inc. N-aryl-N-(4-piperidinyl)amides and pharmaceutical compositions and method employing such compounds
DK623586A (da) * 1985-12-27 1987-06-28 Eisai Co Ltd Piperidinderivater eller salte deraf og farmaceutiske kompositioner indeholdende forbindelserne

Also Published As

Publication number Publication date
FI885035L (fi) 1989-05-03
FI885035A7 (fi) 1989-05-03
MX9203140A (es) 1992-07-01
DK607988D0 (da) 1988-11-01
JPH0552834B2 (en, 2012) 1993-08-06
NO884842L (no) 1989-05-03
NO172691C (no) 1993-08-25
AU2455888A (en) 1989-05-04
DE3854938D1 (de) 1996-03-07
KR890008094A (ko) 1989-07-08
ES2081810T3 (es) 1996-03-16
DK172787B1 (da) 1999-07-19
GR3019342T3 (en) 1996-06-30
CN1020723C (zh) 1993-05-19
IL88140A0 (en) 1989-06-30
JPH0215061A (ja) 1990-01-18
EP0315405B1 (en) 1996-01-24
NZ226634A (en) 1990-07-26
US4791121A (en) 1988-12-13
CN1041585A (zh) 1990-04-25
DK607988A (da) 1989-05-03
FI885035A0 (fi) 1988-11-01
NO172691B (no) 1993-05-18
JPH02152963A (ja) 1990-06-12
NO884842D0 (no) 1988-10-31
KR970008313B1 (ko) 1997-05-23
DE3854938T2 (de) 1996-05-30
EP0315405A1 (en) 1989-05-10
AU611728B2 (en) 1991-06-20

Similar Documents

Publication Publication Date Title
CA1281719C (en) N-aryl-n-(4-piperidinyl)amides and pharmaceutical compositions and methods employing such compounds
EP0468187B1 (en) Cyclic amide derivatives
EP0863141B1 (en) Substituted heteroaromatic derivatives
EP0266922B1 (en) Dihydropyridine derivatives, their preparation and their use
US4791112A (en) N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US5789422A (en) Substituted arylalkylamines as neurokinin antagonists
DE69330823T2 (de) Thiacyclische piperidinylderivate
CA2081134A1 (en) Hiv protease inhibitors
CA1334416C (en) 4-phenyl-4-¬n-(phenyl)amido|piperidine derivatives and pharmaceutical compositions and method employing such compounds
JPH0673038A (ja) ビフェニル誘導体、これらの化合物を含む医薬組成物及びそれらの調製法
JPH0867670A (ja) 置換４−フエニル−６−アミノ−ニコチン酸誘導体の薬剤としての利用
EP0537201B1 (en) 1-[4-(imidazol-1-yl)benzoyl]piperidine derivatives as antiarrhythmic agents
KR100238562B1 (ko) 피페리딘 유도체 화합물
US4261990A (en) N-alkyleneiminoalkyl-dicarboximides as antiallergics and antiasthmatics
US5013742A (en) 4-phenyl-4-N-(phenyl) amido piperidine derivatives and pharmaceutical compositions and method employing such compounds
US5095022A (en) Piperidine derivatives and pharmaceutical compositions comprising the same
EP0398413A1 (en) "3,4-dehydropiperidine derivatives having psychotropic activity
KR100664893B1 (ko) 신규한 이소퀴놀린 유도체 또는 이의 염
US4957929A (en) 4-phenyl-4-[N-(phenyl)amido]piperidine compounds and pharmaceutical compositions employing such compounds
US4921864A (en) 4-Phenyl-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds
US4639522A (en) 1-benzyl-3,5-dimethyl-4-piperdyl ester of a Hantzsch dihydropyridine
WO1990001025A1 (en) Enamine quaternary compounds, methods of making and their use as muscle relaxants
US4900738A (en) N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and their use as analgesics
US4546105A (en) Pyrrolylaminopiperidines, compositions thereof and methods of use
US4801615A (en) 4-heterohexacyclic-4-(N-(phenyl)amido) piperidine derivatives and pharmaceutical compositions and method employing such compounds

Legal Events

Date Code Title Description
MKLA Lapsed